Cases 41 - 50 of 235
Bayer Intellectual Property GMBH et al v. Epic Pharma, LLC
as 1:2022cv01481
Plaintiff:
Bayer Intellectual Property GMBH, Bayer Pharma AG, Bayer AG and others
Defendant:
Epic Pharma, LLC
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Gilead Sciences, Inc. et al v. Apotex Inc. et al
as 1:2022cv01399
Plaintiff:
Gilead Sciences, Inc., Gilead Sciences Ireland UC, Janssen Products, L.P. and others
Defendant:
Apotex Inc. and Apotex Corp.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv01228
Plaintiff:
Bayer Pharma AG and Bayer AG
Counter Defendant:
Janssen Pharmaceuticals Inc.
Defendant:
Mylan Pharmaceuticals Inc.
Counter Claimant:
Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. MANKIND PHARMA LIMITED
as 2:2022cv05599
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER AG and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MANKIND PHARMA LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED
as 3:2022cv05485
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, BAYER AG and others
Defendant:
USV PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
BAYER INTELLECTUAL PROPERTY GMBH et al v. USV PRIVATE LIMITED
as 2:2022cv05485
Plaintiff:
BAYER INTELLECTUAL PROPERTY GMBH, BAYER PHARMA AG, BAYER AG and others
Defendant:
USV PRIVATE LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Bayer Pharma AG, et al v. Mylan Pharmaceuticals Inc. et al
as 1:2022cv00063
Plaintiff:
Bayer Pharma AG,, Bayer AG, and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc. and Mylan Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Hetero Labs Limited Unit V et al
as 1:2022cv00696
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Defendant:
Hetero Labs Limited Unit V and Hetero USA, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. HETERO LABS LIMITED UNIT V et al
as 2:2022cv03212
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC., THE REGENTS OF THE UNIVERSITY OF CALIFORNIA and others
Defendant:
HETERO LABS LIMITED UNIT V and HETERO USA, INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Aragon Pharmaceuticals, Inc. et al v. Eugia Pharma Specialities Limited et al
as 1:2022cv00688
Defendant:
Eugia Pharma Specialities Limited, Eugia Pharma Specialties Limited, Aurobindo Pharma USA, Inc. and others
Plaintiff:
Aragon Pharmaceuticals, Inc., Janssen Biotech, Inc., The Regents of the University of California and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
